Join us in London to discuss diagnostics for Antimicrobial Resistance
In a recent report, the World Health Organisation reiterated concerns that not enough antibiotics are in development. Along with making new antibiotics, we also need to manage demand for these medicines. For example, in the US, it is estimated more than 2/3 of antibiotics prescribed to treat respiratory problems are unnecessary, that equates to about 27 million doses a year. Reducing the over-consumption of antibiotics is multifaceted involving stewardship programmes, regulation and crucially diagnostics. In his final report for the Review on AMR, Lord Jim O’Neill outlined how “doctors must still prescribe antibiotics based only on their immediate assessment of a patient’s symptoms, just like they used to when antibiotics first entered common use in the 1950s.”
Rapid, high quality and affordable diagnostics are urgently needed. As part of the Learned Society Partnership on AMR (LeSPAR), we are bringing together experts to discuss some of the challenges facing discovery, development and use of diagnostics for infectious disease. Topics covered at the workshop will include the clinical challenges, molecular diagnostics, metrology and analytical technologies. With a particular focus on supporting early career researchers from academia and industry, we hope to stimulate links across the many disciplines and sectors needed to realise a healthy pipeline of new diagnostics tests and technologies. We hope that you can join us in London on 20 November 2017.
Secure you place by registering online now at rsc.li/diagnostics4AMR
Early bird registration deadline – 02 October
Standard registration deadline – 06 November
